Jen L, PhD
LightNews LightNews
banner
drjkyl.bsky.social
Jen L, PhD
@drjkyl.bsky.social
2.4K followers 14K following 260 posts
Executive Editor/Team Leader Open Access Science Journals Sage Publishing
Opinions = mine

http://linkedin.com/in/jlovick-editor

#oncology #cancerresearch #medicine #biology #cardiology #neurology #microbiology #publichealth #healthcare #technology
Posts Replies Media Videos
Pinned
drjkyl.bsky.social
Jen L, PhD @drjkyl.bsky.social · Feb 21
Introduction - PhD working in academic publishing, lead a team of amazing Managing Editors that support @sagepub.com @journals.sagepub.com 's Open Access Biomedical Journals. I'll be sharing recent articles from our journals that I find interesting. Happy to connect with researchers! 📖🔬🧪💊⚕️
drjkyl.bsky.social
Histone deacetylase in human sarcomas
The International Journal of Biological Markers
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#personalizedtherapy #precisionmedicine #cancer #oncology #openaccess
November 17, 2025 at 5:34 PM
drjkyl.bsky.social
Urothelial carcinoma and the potential clinical application of urinary extracellular vesicles: Current Status and prospects
Bladder Cancer Journal
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#cancerbiomarker #liquidbiopsy #oncology #openaccess
November 17, 2025 at 5:30 PM
drjkyl.bsky.social
Plasma matrix metalloproteinases 7 and 8 and tissue inhibitor of metalloproteinases 1 as prognostic biomarkers in colorectal cancer
The International Journal of Biological Markers
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#cancerprognosis #oncology #openaccess
November 17, 2025 at 5:27 PM
drjkyl.bsky.social
Harnessing T-cell therapy for lupus nephritis: Opportunities and challenges
@celltransplant1992.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#autoimmune #inflammation #immunology #medicine #openaccess
November 17, 2025 at 5:24 PM
drjkyl.bsky.social
Microbiota-targeted strategies in IBD: therapeutic promise of 2′-fucosyllactose and beyond
@tagastroenterol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#gastroenterology #microbiome #inflammation #medicine #openaccess
November 17, 2025 at 5:20 PM
drjkyl.bsky.social
Balloon-assisted ERCP for bile duct stones in surgically altered anatomy: current techniques, devices, and evolving strategies
@tagastroenterol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#endoscopy #gastroenterology #healthcare #medicine #openaccess
November 17, 2025 at 5:18 PM
Reposted by Jen L, PhD
linglingtian.bsky.social
Wrapping up an inspiring #SIBCS2025 in Shanghai. So many brilliant minds working to transform breast cancer care.

Thanks to everyone who stopped by booth #29 to chat about publishing with Sage Journals! #Oncology #BreastCancer #MedicalJournals
November 15, 2025 at 10:00 AM
Reposted by Jen L, PhD
naturalproductcomm.bsky.social
Top Read Papers on Natural Product Communications - October 2025

💡 3. Phytochemical Analysis, Anti-Hemolytic Activity, and In Vitro Evaluation of Antioxidant, Antimicrobial, Anti-Diabetic, and Anti-Inflammatory Properties of Extracts from Psidium guajava Linn.

journals.sagepub.com/doi/10.1177/...
November 14, 2025 at 12:57 PM
Reposted by Jen L, PhD
taneuroldisord.bsky.social
Could #MultipleSclerosis phenotypic profiles be distinguishable at diagnosis?
Aurora Zanghi and colleagues use a multimodal #biomarker approach to investigate:
journals.sagepub.com/doi/full/10....
November 14, 2025 at 12:14 PM
Reposted by Jen L, PhD
linglingtian.bsky.social
Kicking off #SIBCS2025 in Shanghai! Proud to represent Sage Publishing as Editor of Therapeutic Advances in Medical Oncology and Co-Editor of Clinical Medicine Insights: Oncology + Rare Tumors.

Come say hi at booth #29! 🧬📚 #BreastCancer #Oncology #MedicalResearch
November 14, 2025 at 2:36 AM
Reposted by Jen L, PhD
taneuroldisord.bsky.social
New study by Matteo Foschi et al reveals sex-specific patterns in #MultipleSclerosis progression:
Women—especially postmenopausal—face higher risk of disability worsening independent of relapses, while men experience greater impact per event:
journals.sagepub.com/doi/full/10....
November 11, 2025 at 10:09 AM
Reposted by Jen L, PhD
celltransplant1992.bsky.social
Advanced medical treatments for hair loss
doi.org/10.1177/0963...
#stemcell #EV #transplantation #hair
@journals.sagepub.com
November 11, 2025 at 12:27 PM
Reposted by Jen L, PhD
celltransplant1992.bsky.social
From “stem” to “stromal”: Reframing the nomenclature of mesenchymal stromal cell therapy
doi.org/10.1177/0963...
#MSC #stemcell #celltherapy
@journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
doi.org
November 11, 2025 at 12:35 PM
Reposted by Jen L, PhD
celltransplant1992.bsky.social
Autologous stem cell transplantation meets CAR-T therapy: A synergistic strategy for B-cell lymphoma
doi.org/10.1177/0963...
#stemcell #CarT #lymphoma
@journals.sagepub.com
November 11, 2025 at 12:43 PM
Reposted by Jen L, PhD
cancer-control.bsky.social
Single-centre (@petermaccc.bsky.social) real-world data on #BiliaryTractCancer: 1st line gem/cis+ICI yields outcomes comparable to pivotal trials. ECOG & albumin predict survival. #HER2 amp = worse OS; dMMR & #BRCA = trend toward improved OS. Study highlights importance of molecular profiling.
November 11, 2025 at 4:00 PM
Reposted by Jen L, PhD
tainfdis.bsky.social
A multistep UTI-focused stewardship initiative reduced unnecessary treatment of asymptomatic presentations by 12% & improved adherence to UTI management guidelines.
journals.sagepub.com/doi/full/10....
Impact of a multistep urinary tract infection-focused disease state stewardship initiative on the treatment of asymptomatic urinary presentations: a retrospective cohort study - Christian Tyler Pitcoc...
Background: Asymptomatic bacteriuria (ASB) is often overtreated, risking patient harm through unnecessary antimicrobial use and fostering antimicrobial resistan...
journals.sagepub.com
November 11, 2025 at 9:07 PM
Reposted by Jen L, PhD
taneuroldisord.bsky.social
A new RCT online!
Lisa Schäfer and colleagues show how multidisciplinary online care can improve mental health, vitality, and quality of life in women with X-linked adrenoleukodystrophy - a model that could be scaled for other rare disorders.
#RareDisease
journals.sagepub.com/doi/pdf/10.1...
November 12, 2025 at 10:29 AM
Reposted by Jen L, PhD
naturalproductcomm.bsky.social
Prof. K. Husnu Can Baser and team's work on Menthol

💡 Menthol: A Comprehensive Review of Its Pharmacological Properties and Therapeutic Applications

"Clinical data showed effectiveness in irritable bowel syndrome, headache disorders, and skin care."

Details: journals.sagepub.com/doi/full/10....
November 12, 2025 at 11:46 AM
Reposted by Jen L, PhD
linglingtian.bsky.social
ADCs are transforming breast cancer care, but toxicity management remains key to patient outcomes. Read the full review 👉 buff.ly/Fp2c5JI #BreastCancer #Oncology #ADCs #CancerResearch
November 13, 2025 at 8:15 AM
Reposted by Jen L, PhD
tamedoncol.bsky.social
🔬 New insights into HER2-low TNBC: • 47.7% of Asian TNBC patients classified as HER2-low • Distinct genomic profile (↓ BRCA1, ↑ PIK3CA) • No difference in survival outcomes vs HER2-zero

Full study 👉 buff.ly/kXKMwn8 #BreastCancer #HER2 #CancerResearch
November 13, 2025 at 8:15 AM
Reposted by Jen L, PhD
taneuroldisord.bsky.social
Is increased middle cerebral artery peak systolic velocity associated with the development of malignant media infarction after endovascular thrombectomy?
Find out more in this study, recently published in Therapeutic Advances in Neurological Disorders: #stroke
journals.sagepub.com/doi/full/10....
November 13, 2025 at 9:29 AM
drjkyl.bsky.social
Very excited that Therapeutic Advances in Medical Oncology Editor, Lingling Tian, is at #SIBCS2025!!

@journals.sagepub.com
linglingtian.bsky.social Lingling Tian @linglingtian.bsky.social · 4d
Kicking off #SIBCS2025 in Shanghai! Proud to represent Sage Publishing as Editor of Therapeutic Advances in Medical Oncology and Co-Editor of Clinical Medicine Insights: Oncology + Rare Tumors.

Come say hi at booth #29! 🧬📚 #BreastCancer #Oncology #MedicalResearch
November 14, 2025 at 4:06 AM
Reposted by Jen L, PhD
linglingtian.bsky.social
How poor is the prognosis for dialysis-dependent #MultipleMyeloma? This multicenter study confirms it's severe, but also identifies a path to hope. Achieving dialysis independence TRIPLES median overall survival.
Key factors: VGPR, daratumumab, deep early light chain response.
Dialysis dependence is associated with poor prognosis in multiple myeloma: a multicenter retrospective cohort study - Ji-nuo Wang, Chenyun Wang, Jinping Ying, Gaofeng Zheng, Xiaoyan Han, Peng An, Gang Wang, Fei Chen, Li Yang, Yang Yang, Donghua He, Jingsong He, Yuanshuai Chen, Wenjun Wu, Zhen Cai, 2025
Background: Patients with multiple myeloma (MM) and renal impairment (RI), particularly those requiring dialysis, have historically experienced poor outcomes. D...
buff.ly
November 10, 2025 at 8:15 AM
Reposted by Jen L, PhD
tamedoncol.bsky.social
Could the clock be a treatment factor? This retrospective study of 248 patients with mGC found better survival outcomes when nivolumab was infused before mid-afternoon.

Authors suggest infusion timing should be considered in daily practice. Details here: buff.ly/k54we7o
November 10, 2025 at 9:21 AM